The first quarter 2007 sales and earnings were reviewed Mr. Hanspeter Spek, Executive Vice President, Pharmaceutical Operations and Mr. Jean-Claude Leroy, Executive Vice President, Finance and Legal. The presentation was followed by a Q&A session.
Recorded audio webcast held on May 3 at 8 a.m (CET)